| Michael B Rousseau, MD | |
|
4360 Ferguson Dr Ste 100, Cincinnati, OH 45245-1683 | |
| (513) 841-7750 | |
| (513) 841-7751 |
| Full Name | Michael B Rousseau |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 34 Years |
| Location | 4360 Ferguson Dr Ste 100, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851328660 | NPI | - | NPPES |
| 340011132 | Other | OH | RAILROAD MEDICARE |
| 0901073 | Medicaid | OH | |
| 64955214 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 35-06-4460 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - Clermont Hospital | Batavia, OH | Hospital |
| Mercy Health-anderson Hospital | Cincinnati, OH | Hospital |
| Bethesda North | Cincinnati, OH | Hospital |
| The Jewish Hospital-mercy Health | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tri State Urologic Services Psc Inc | 6204740889 | 56 |
News Archive
Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU's Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system that significantly enhances the effectiveness of treatment for the aggressive skin cancer melanoma.
The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease
Scientists are proposing an international effort, on the scale of the Human Genome Project (HGP), to identify all the proteins present in cancer cells. HGP was the international scientific research project that identified and mapped all the genes in humans.
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. HER2-positive breast cancer gets its name from a protein called human epidermal growth factor receptor 2 that promotes cancer cell growth.
› Verified 9 days ago
| Entity Name | Tri State Urologic Services Psc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396938312 PECOS PAC ID: 6204740889 Enrollment ID: O20031118000285 |
News Archive
Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU's Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system that significantly enhances the effectiveness of treatment for the aggressive skin cancer melanoma.
The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease
Scientists are proposing an international effort, on the scale of the Human Genome Project (HGP), to identify all the proteins present in cancer cells. HGP was the international scientific research project that identified and mapped all the genes in humans.
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. HER2-positive breast cancer gets its name from a protein called human epidermal growth factor receptor 2 that promotes cancer cell growth.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael B Rousseau, MD 2000 Joseph E Sanker Blvd, Cincinnati, OH 45212-1979 Ph: (513) 841-7400 | Michael B Rousseau, MD 4360 Ferguson Dr Ste 100, Cincinnati, OH 45245-1683 Ph: (513) 841-7750 |
News Archive
Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU's Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system that significantly enhances the effectiveness of treatment for the aggressive skin cancer melanoma.
The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease
Scientists are proposing an international effort, on the scale of the Human Genome Project (HGP), to identify all the proteins present in cancer cells. HGP was the international scientific research project that identified and mapped all the genes in humans.
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. HER2-positive breast cancer gets its name from a protein called human epidermal growth factor receptor 2 that promotes cancer cell growth.
› Verified 9 days ago
Dr. Ayman Mahdy, Urology Medicare: Accepting Medicare Assignments Practice Location: 222 Piedmont Ave, Cincinnati, OH 45219 Phone: 513-475-8787 Fax: 513-475-7348 | |
Pramod P Reddy, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3333 Burnet Avenue, Ml 5037, Cincinnati, OH 45229 Phone: 513-636-4975 Fax: 866-213-7089 | |
Justin Cox, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2123 Auburn Ave, Cincinnati, OH 45219 Phone: 513-721-7373 Fax: 513-977-4253 | |
Brian Joseph Minnillo, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4360 Ferguson Dr Ste 100, Cincinnati, OH 45245 Phone: 513-841-7750 Fax: 513-841-7751 | |
Philip J Buffington, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 4360 Ferguson Dr Ste 100, Cincinnati, OH 45245 Phone: 513-841-7750 Fax: 513-841-7751 | |
Richard H Keys, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2000 Joseph E Sanker Blvd, Cincinnati, OH 45212 Phone: 513-841-7400 Fax: 513-841-7402 | |
Marc J Pliskin, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 3301 Mercy Health Blvd, Suite 525, Cincinnati, OH 45211 Phone: 513-841-7700 Fax: 513-841-7701 |